⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8917609 | 1.00 | — | — | |
| SCHEMBL8917931 | 0.89 | ADRA1D (0.31) | — | |
| SCHEMBL8917939 | 0.89 | ADRA1D (0.31) | — | |
| SCHEMBL9523947 | 0.88 | — | — | |
| SCHEMBL8916677 | 0.86 | KDM4E (0.31) | — | |
| SCHEMBL8916664 | 0.86 | KDM4E (0.31) | — | |
| SCHEMBL9524945 | 0.79 | HTR1A (0.40) | — | |
| SCHEMBL9524949 | 0.79 | HTR1A (0.40) | — | |
| SCHEMBL9524937 | 0.77 | MEN1 (0.45) | — | |
| SCHEMBL9525010 | 0.77 | SLC5A2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5651918-A | Optically active 1,3-dioxolane derivatives carrying a mesogenic radical in the 4-position, a process for their preparation and their use as doping agents in liquid-crystal mixtures | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-07-29 | — | — | US | disclosed |
| EP-0351746-B1 | Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures | HOECHST AG (DE) | 1993-12-29 | — | — | EP | disclosed |
| EP-0351746-A1 | Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-01-24 | — | — | EP | disclosed |